\(-ㅂ-)/♡ try ViralVideoDB.com daily viral videos

Addition of Bevacizumab to Up-front therapy for EGFR+ NSCLC

Say and pronounce Addition Of Bevacizumab on SuperTTS.com Make Your Own Text-To-Speech Words Instantly

  Info

Description

Panelists Mark Socinski, MD; Vali Papadimitrakopoulou, MD; Jared Weiss, MD; Alexander Drilon, MD; and Tracey Evans, MD, describe when to add bevacizumab to an EGFR TKI in non–small cell lung cancer.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You

Related

  Upfront EGFR-Targeted Therapy for NSCLC   New Therapies for HNSCC   EGFR TKIs for Upfront Treatment of NSCLC   Treatment of Metastatic EGFR-Positive NSCLC   Upfront Use of Osimertinib in EGFR+ NSCLC   Treatment for EGFR+ NSCLC   NSCLC Immunotherapy: Transformation of Upfront Therapy - O   NSCLC Immunotherapy: Transformation of Upfront Therapy   EGFR Testing for NSCLC   Dr. Chaft on Ongoing Pivotal Trials in EGFR-Mutant NSCLC   Dr. Ramalingam on FLAURA Findings in EGFR-Mutant NSCLC   Dr. Peters on the FLAURA Trial for EGFR-Mutated NSCLC   Dr. Peters Discusses the FLAURA Trial for EGFR-Mutated NSCLC   Dr. Papadimitrakopoulou on Treatment Options for EGFR-Mutant NSCLC   Dr. West on Emerging Changes in the Field of EGFR-Mutant NSCLC   Treatment Options for Advanced Colorectal Cancer   Duration of Upfront Immunotherapy for NSCLC   Duration of Upfront Immunotherapy for NSCLC - O   Dr. Govindan on the Future of EGFR-Mutant NSCLC   Upfront Antiangiogenic Therapy in Advanced Ovarian Cancer   Dr. Husain on the Future of Monitoring T790M in Lung Cancer   Dr. Levine on Simulation in the Management of EGFR-Mutated Advanced NSCLC   Upfront Immunotherapy for NSCLC   First- and Later-line Use of Panitumumab in Metastatic Colorectal Cancer   Sequencing of Therapies in EGFR-Mutant NSCLC   Upfront Immunotherapy + Chemotherapy for NSCLC   Reconsideration of Gefitinib in EGFR-Mutant NSCLC   Understanding EGFR-Mutant NSCLC Subsets   EGFR-Resistant Disease in Lung Cancer   Plasma Testing for NSCLC EGFR & ALK Mutations   Development of ALK-Targeted Therapy for NSCLC   Maintenance Strategies in Lung Cancer   CALGB 80405 Trial Results in Metastatic Colorectal Cancer   Maintenance Therapy for Squamous NSCLC   Relapsed or Refractory EGFR+ NSCLC   Emerging Options for Treatment of EGFR-Positive NSCLC   Dr. Garassino Discusses Promising Findings With Osimertinib for Patients With NSCLC and Brain Mets   NSCLC: EGFR Inhibition and Resistance Mechanisms   Dr. Gubens on Prevalence of EGFR/ALK/ROS1 and PD-L1 Expression in NSCLC   Induction Therapy for MCL   EGFR-Targeted Therapy for Squamous NCSLC   Patient Selection for Upfront Immunotherapy in NSCLC   CLL: Factors for Upfront Therapy   EGFR & ALK/ROS1 Testing in Squamous NSCLC   Third-Generation EGFR Inhibitors in NSCLC   Upfront Immunotherapy for PD-L1+ NSCLC   Frontline Afatinib in EGFR-Mutant NSCLC   Choosing Second-Line Therapy for ALK+ NSCLC   Choosing Second-Line Therapy for Squamous NSCLC   Osimertinib for EGFR T790M Resistance Mutations in NSCLC   Recent FDA Approval of Ribociclib as Upfront Therapy   Dr. Wakelee on Detection of EGFR T790M Mutation in NSCLC   Study Finds HER2 Breast Cancer Driver In 3 Percent Of Lung Cancers   The Current Role for Antiangiogenic Therapy for NSCLC   Options for Upfront Therapy in MCL   Combination Approaches for Second-Line Therapy for NSCLC   Patient Selection for Upfront Immunotherapy in NSCLC - O   Dr. Suresh Ramalingam on Frontline Osimertinib Data in EGFR+ NSCLC   Upfront Use of Second-Generation TKIs in ALK+ NSCLC   Upfront Use of Second-Line Agents in ALK+ NSCLC   Upfront Use of Next-Generation ALK Inhibitors in NSCLC   The Potential for IO Use as Maintenance Therapy in NSCLC   Immuno-Oncology Combination Therapy in NSCLC   The Evolution of ALK/ROS1-Targeted Therapy in NSCLC   Dr. Brahmer on 5-Year Follow-Up Data for Nivolumab in NSCLC   Choosing Frontline and Second-line Therapy for NSCLC   Dr. Furman on Considering Factors for Upfront Therapy in CLL   AZD9291 and Rociletinib in T790M-Mutant NSCLC   Efficacy and Safety of Afatinib vs Erlotinib and Gefitinib in EGFR+ NSCLC   Bevacizumab for Recurrent Ovarian Cancer   New Therapies for Squamous NSCLC   Upfront Therapy for Myeloma; Impact on Choice at Relapse   Choosing Between Anti-VEGF and Anti-EGFR Targeted Therapy   Probability in Genetics: Multiplication and Addition Rules   Combined Immunotherapy and Chemotherapy for NSCLC

Popular Today

  The enemy of your enemy is your friend.   Q conference   Capital Markets: An AFP Policy Briefing   OU Football: Riley addresses roster changes, gives team update   Which NBA teams could land a trade for Damian Lillard? Colin Cowherd decides | NBA | THE HERD   Minneapolis Protesters Climb On Tractor-Trailer Following Conviction of Derek Chauvin   Weakest Police Blockade Ever? D.C. Cops Bust Through BLM Human Chain   Fauci Suggests Locked Down States Are Doing Worse than Texas Because People Are Ignoring Lockdowns   Chris Broussard talks Brooklyn/Milwaukee, Chris Paul, predicts Clippers/Jazz series | NBA | THE HERD   Biden Shuts Down Press When Asked About MN Shooting: "Whoa. Whoa. Whoa. Whoa. Whoa. Whoa. Whoa."   Exclusive Leaked Video: Human Smugglers Drop Small Children from Border Wall in New Mexico   Cruz Scolds Dems: "When You Disarm Law-Abiding Citizens You Make Them More Likely to Be Victims"   Jen Psaki Struggles to Explain Why Migrants Get Hotel Rooms   Colin Cowherd rates the panic levels of each NBA playoff team | NBA | THE HERD   Ouch! Biden Stumbles Multiple Times Boarding Air Force One   Former President Donald John Trump Acquitted   Stonetoss & How Hate Speech Spreads   Occupy: Boise Demonstration   AOC's BRILLIANT Floor Speech on Dark Money Corruption in DC, Climate Change, & the Green New Deal   "I'D BE EMBARRASSED!!!" Alexandria Ocasio-Cortez CALLS OUT Republicans For Not Reading Bills   Prager-U at it again with their brazen and disgusting propaganda. Blaming the victim: an American pass-time.   Uriah Hall Reflects on His TUF Experience   Dead Space Remake revealed | Totally Rated   Rise of Sean Strickland   Microsoft sparks anger by charging Hotmail and Outlook users to keep their old emails   OU football: Defense rattles Cowboys   Real Solutions: A Discussion on Criminal Justice Reform   Should the populist left ever work with the populist right? - System Update with Glenn Greenwald   LGBTQ+ Gaming Week on TechRadar and the craziest things we saw at CES   Bantamweight Breakdown With TJ Dillashaw   Krystal and Saagar: Biden Justice Department DROPS Cuomo Nursing Home Investigation   Krystal and Saagar: Biden's Bad 6 Month Marks Could Spell DOOM For Dem Midterms   Drone flight around the Acropolis of Athens, Greece   How Do I Get On Budget with An Irregular Income?   PM Imran Khan befitting reply to afghan reporter | Dawn News   I Live In a Movie Theater, Is It Time To Sell It?   Best MLB Bets for July 28, 2021, from Joe Osborne   Vermont leaders hold latest press briefing   I'm Stuck With A Limited Income And Don't Know What To Do!   Tokyo Olympics Men's Golf Odds + Picks - Tokyo 2020 Betting   Drone flight over the archaeological site of Epidaurus, Greece   My Parents Want Me to Fund Their Retirement Because I "Owe Them"   2021 NFL Division Odds + Value Picks - NFL Betting   What caused the defeat of PML-N in Sialkot by-election? Mujeeb-ur-Rehman Shami Analysis   Strawberry Scandal   Best MLB Bets for July 27, 2021 from Joe Osborne   Vermont leadership predicts continued rise in new COVID-19 cases   I Don't Have a Good Reason, But I Want a Divorce!   Best MLB Bets for July 26, 2021 from Joe Osborne   Drone flight over Tolo, Greece in the winter   View All Today's Popular Videos